report.indd
|
|
- うまじ ちゅうか
- 7 years ago
- Views:
Transcription
1
2
3
4
5
6
7
8 *: p<0.05 **: p<0.01 ***: p<0.001
9 *: p<0.05 **: p<0.01 ***: p<0.001
10 *: p<0.05 **: p<0.01 ***: p<0.001
11
12
13
14
15
16 SOD NOX SOX SOD SOD
17 SOD NOX SOX SOD SOD
18 C E,
19
20 B B B B B B B B
21 PH8.5
22 21
23 ROO 0.02
24
25 4,5 B1
26 ( H.
27 OH OH C C C C C C E H PH
28 300mg 400mg
29 5,6 30
30 C E PH PH
31
32 12 1 B
33
34 mg 80mg
35 BMI BMI BMI PH NK (
36 50 26 BMI25
37
38 ,3 A1C
39 GI GI
40 20 30 OK
41 50 LDL LDL LDL LDL LDL LDL LDL LDL LDL LDL LDL HDL
42 LDL LDL LDL LDL HDL A C
43 60mg 90mg mg 90mg
44
45 A1C C E C C
46 50 100
BMI BMI
() () 2 QOL () () QOL 11 6 14 20 13.9 20 BMI 12 70 40 11 6 14 20 13.9 20 BMI 12 70 40 57.1 100 ) 1 100 1 250 11 11 430 315 73.3 494 247 50.0 322 60 18.6 12 70 62 88.6 100 18 57.1 1 100 1 250 430 315 73.3
More information[] 1
0 [] 1 [] 2 [] 2010 22 0% 20% 40% 60% 80% 100% 15.4 65.2 10.8 8.6 12,000 2010 22 2020 32 2030 42 2040 52 2015 27 14.3 63.3 12.3 10.1 10,000 2020 32 13.2 63.0 11.9 11.9 8,000 2025 37 12.3 62.9 10.6 14.2
More informationMicrosoft Word - 表紙資料2-4
(1) / 130 g 25 g 520% 170 g 30 g 560% 70 mg 600 mg 11.6% 0 10.5 mg 0% (1) (2) / 50100 g 25 g 200400% 50100 g 30 g 167333% 5001000 mg 600 mg 83167% 1020 mg 10.5 mg 95190% (2) / (1) 45.6 g 30 g 152% (2)
More informationAC-2
AC-1 AC-2 AC-3 AC-4 AC-5 AC-6 AC-7 AC-8 AC-9 * * * AC-10 AC-11 AC-12 AC-13 AC-14 AC-15 AC-16 AC-17 AC-18 AC-19 AC-20 AC-21 AC-22 AC-23 AC-24 AC-25 AC-26 AC-27 AC-28 AC-29 AC-30 AC-31 AC-32 * * * * AC-33
More informationエンジョイ北スポーツ
28 3 20 85132 http://www.kita-city-taikyo.or.jp 85 63 27 27 85132 http://www.kita-city-taikyo.or.jp 2 2 3 4 4 3 6 78 27, http://www.kita-city-taikyo.or.jp 85132 3 35 11 8 52 11 8 2 3 4 1 2 4 4 5 4 6 8
More information16 10 19
16 10 19 1 1 10 10 11 10 12 10 2 13 10 14 10 15 16 15 17 15 18 15 19 15 20 21 20 22 20 23 20 24 20 3 26 28 29 30 31 32 33 34 35 36 38 39 40 41 42 4 10 10 11 10 12 10 13 10 5 14 10 15 16 15 17 15 18 15
More informationN 847 1085 1932 2966 3336 6302 % 43.8 56.2 100 47.1 52.9 100 28 72 41.34 28 77 51.52 N 84 750 580 478 28 12 1932 % 4.3 38.8 30.0 24.7 1.4 0.6 100 N 1079 2710 1318 1083 60 52 6302 % 17.1 43.0 20.9 17.2
More information1 2 3 4 5 68g 9g 2g 0.2mg 0.8mg 316kcal 316cal 326kcal 326cal 6 010 3035 15 5355 30 120 20 7 8 9 10 11 () () () 12 1 3 1 5 1 80kcal 20 30 20 30 1 9 7.5 13 7.58.5 910.5 1213.5 11.512.5 14 15 79 23 1520
More informationA B 1.A B A B 2.A B A B 3.A
1 1. 2.WHO 3. 4. 5. 2 2.0mg/kg / 1. 2. 3. 4. 5. 3 1. 90 2. 3. 4. 5. 4 1. 2. 3. 4. 5. 1 21 5 1. 2. 2050 61 3. 1 4. 5. 6 1. ----------- 2. ---- 3. ------ 4. -------- 5. --------- 7 A B 1.A B------------------A
More information&
& & & c & B & c & & aa c c a a nk a a & a aa aaa & A A A A & 7 & & c og og & c c k g a og ok c c & 7 7 n & aa & & & & & & & & & & & g & & a a & & 171 1 & 1 7 1 1 6 de 666 66 6 7 6 f 6 & & c & 1 1 1 1 1
More information3 JAS JAS JAS 4
1 2 3 JAS JAS JAS 4 5 6 7 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ph 102 106 K 31 32 13 3 15 79 33 34 35 36 37 20 6 H.22.3 http://www.caa.go.jp/foods/pdf/syokuhin19.pdf 38
More informationQ A ワークショップ 肥 満 症 Q&A パート1 概 念 成 因 合 併 症 Q1: 長 谷 川 和 田 LDL HDL EPA LDL HDL EPA HDL CRP () 和 田 中 村 相 澤 Q2:HbA1C 長 谷 川 佐 藤 m
Vol. 17 No. 1 2011 トピック 日 本 肥 満 学 会 主 催 第 8 回 肥 満 症 サマーセミナー 特 集 日 本 肥 満 学 会 による 第 8 回 サマーセミナーが2010 年 8 月 28 日 ( 土 ), 新 潟 大 学 有 壬 記 念 館 にて 開 催 されました. ワークショップ 肥 満 症 Q&A から 興 味 深 い 討 論 をいくつか 取 り 上 げ, 本 号
More information株主通信:第16期 中間報告書
9 1 20,000 15,000 10,000 5,000 2007/4 2008/4 2009/4 2010/4 2011/4 2012/4 2013/4 01 02 2 3 03 04 4 05 06 5 133,362 206,945 344,360 363,936 67,583 128,114 819 18,583 412,477 846,445 164,935 422,265 1,433,645
More informationP15 P211 1 P1 P4 P2 P3 P4 P17
P15 P211 1 P1 P4 P2 P3 P4 P17 P3 P4 P7 P8 P9 2 1 Q A P17 P17 1 2 3 4 3 5 6 7 8 2 P17 Q A P17 4 1 2 3 4 2 P17 P4 P12 P17 P4 5 5 6 7 8 2 P4 P4 6 1 2 3 4 3 P17 P10 P17 7 5 6 7 8 4 0120-096-991 P17 8 1 2 3
More information100 BMILDL HDL HbA1c HDL HbA1c(6.1%) 19.02 18.2%45.3% 54.5 45 BMIHDL HbA1c 70 45 60 25 26 27 28 29 30 38 45 53 60 25 26 27 28 29 45 49 53 57 60 20 29 24.28 18.21 BMI HbA1c NGSP HDLLDL GOTGPT-GTP egfr 38.7
More informationuntitled
...1...3 -... 3 -... 3...5 -... 5 -... 5 -... 6 -... 7 -... 7 -... 7 -... 10 -... 17 -... 17 -... 18 -... 20 -... 21 1 TEL 2 3 4 ) ) 5 6 7 8 9 10 11 () (4) () (4) () () 730-0042730-8586 730-0042 730-0042730-8586
More information平成25年度調理師試験問題
25 15 60 HB 2 1 1 2 36 1961 46 1971 56 1981 3 1991 3 4-1 - 5 6 7 8 6 2 12 31 1 15 1 15 4 15 4 15-2 - 9-3 - 10 11 12 13 3-4 - 14 腿 15 16 WHO 22 2010 17 18 1-5 - 19 1 g 4 kcal 4 kcal 9 kcal 9 kcal 20 21
More informationMultiWriter 5650C 活用マニュアル
1 2 3 4 5 6 7 8 9 10 1 2 3 4 5 6 7 8 9 11 1 2 3 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 1 2 3 a b c 30 31 32 C *1 *2 *2 33 2 2 2 2 2 2 2 2 2 34 *1 *2 ± *1 C C 35 36 37 38 39 40 OK 1 2 3 4
More information128 Q2. LCCO 2 LCCO CO 2 CO 2
127 LR3 LR35 LR3 1. CO 2 CO 2 CO 2 CO 2 CO 2 CO 2 CO 2CO 2 LCCO 2 LCCO 2 CASBEE PART LCCO 2 LCCO 2 CO 2 LR2. CO 2 embodied CO 2 LR1. BEICO 2 128 Q2. LCCO 2 LCCO 2 60 30 30 60 90 CO 2 CO 2 129 2. 2.1 5
More information14 12 10 8 6 4 2 0 1 2 3 4 5 6 7 8 9 10 11 12 20 0 0 0 0 0 0 0 0 0 0 0 0 21 0 0 0 0 0 0 0 0 0 0 0 0 22 0 0 0 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 0 0 0 0 0 0 0 24 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 0 0
More information1% 51% 4% 13% 31% 152 50 47 36 32 21 20 20 16 14 7 3 1
1% 13 13 19 20 1% 80 9% 70 41% 60 34% 30 3% 40 5% 50 6% 51% 2% 47% 3% 1% 14% 10% 23% 49% 1% 51% 4% 13% 31% 152 50 47 36 32 21 20 20 16 14 7 3 1 102 228 OK 228 46 42 17 10 8 6 5 1 14% 25% 1% 3% 7% 27% 23%
More information387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )
386 B B () () ( ) ( ) ( ) 387 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 388 ( ) ( ) ( ) 389 ( ) 2 ( ) ( ) ( ) ( ) ( ) ( ) ( ) ( ) 390 ( ) ( ) ( ) () () ( ) Hot flush 391 ( ) ( ) ( ) 392 ( ( )
More informationMNT MNT CVD MNT 1) 2) 3) 4) MNT 1) 1 2 2) MNT MNT MNT MNT 1 1 2 1 % HbA1C 2
2008 American Diabetes Association, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008 Jan; 31 Suppl 1: S61-S78.
More informationuntitled
1 2 2 2 3 3 4 4 5 9 6 9 7 10 8 13 1 34 2 46 1 46 2 51 3 54 4 58 5 64 72 74 76 78 80 81 82 86 90 94 98 99 99 100 104 106 108 112 113 114 115 116 117 118 119 119 120 121 122 123 123 124 124 125 125 126 126
More informationGDP GDP 1 98% 2
2016 2016 4 6 [ ] 1 1.1 1.1.1 1. 2. 3. 2 1 4. 1 700-800 1 GDP GDP 1 98% 2 1.1.2 BOD Biochemical Oxygen Demand BOD COD Chemical Oxygen Demand COD DO DO PM2.5 eg.1 GDP CO 2 eg.2 Life Cycle Assessment 3 eg.
More informationA P18 P11 P P1 P4 P17 P3 P4 1
A P18 P11 P P1 P4 P17 P3 P4 1 P3 P4 P7 P8 P9 1 Q A 1 3 4 P17 P17 3 6 7 8 P17 P13 Q A P17 4 1 3 4 P17 P14 P4 P13 P17 P4 6 7 8 P4 P4 6 1 3 4 3 P17 P17 7 6 7 8 4 010-096-991 P17 8 1 3 4 P17 P17 Q A 9 6 7
More information20-121
20 121 150 1 20 121 1 HbA1C 1 2 2 HbA1C 3 2 4 5 HbA1C 1 HbA1C -NH2 -CHO HbA1C 1 1 HbA1C HbA1C HbA1C HbA1C HbA1C 120 HbA1C HbA1C 1 2 2 HbA1C 120 10 10 10 3 β β 1 1 GAD ICA 2 4 HbA1C 2 1 2 5 2 20 121 150
More information1 1881 14 1870 80 1870 1877 10 23 2 3 2 2 24 25 6 1884 17 1 1886 19 1 2 1879 12 1874 7 1879 1884 26 1884.11.2 1884.1.12. 1869 1878 1882 15 5 1884.5.1. 5.10. 27 Oh Lord Amen 1884.5.25. 2 28 2 2 2 2 29 3
More informationBAANs理論に基づく保健指導プログラム暫定版
WHO 4 5 10% L- -3 RNA L - 1960-3 RNA mrna Bio Activating Advanced Nutrients BAANs BAANs BAANs BAANs L- (NO) -3 EPA, DHA) RNA RNA DNA TNF- PAI-1 ( ) BAANs 40 50% 20% 1Kg 7,000Kcal 50Kcal 11 50Kcal
More information大和会だよりvol71
vol. 71 since 1999 http://www.yamatokai.or.jp Column http://www.yamatokai.or.jp/public/lecture/ KH090408 LDL 110 LDL 100 File.2 TEL. 042-562-1411 TEL. 042-566-3111 TEL. 042-566-6631 TEL. 042-562-5738
More informationuntitled
1 4 10 125ha1000m 3 20/m 3 58/m 3 19/m 3 1.5/m 3 1 70m/ha 2 ABC 8000 /m 3 1960 6000 /m 2 3 3 2009 10 19 23 6 7 13 301,000 ha 20 70 50 100 19 200 19 ha 4 20ha 10 30 /100ha 5 1 20ha 10 6 7 2009/09/30 8 100
More information-1-19 753-0214 TEL 083-927-7031083-927-7029 FAX 083-927-0214 e-mail a17201@pref.yamaguchi.lg.jp - 2 - -3-. 20kg 60% 2kg 2 3 -4-30 3 15 3-0.05 0.4 NaOH 0.5 20 -5-. 1 1,757g 69% 30 -6- -7- -8- C C H17 18
More informationml ml ml mg ml ml mm mm mm mm mm mm mm mm mm mm mm ml mmhg mmhg ml Acetylcholine ml mg mm mm mm mm mm mm ope ++ Uribe Davis S H S S : : : : : : : : : G
More information第 1 章 市の概況 1 2 3 4 46 11 3 40 55 7 7 1000 3 5 155ha 488ha 89ha 91ha 10ha 16ha 37ha 930ha ( 14ha ) (10ha 1 ) 44ha 6 第 2 章 公害苦情の概要 7 8 第 3 章 大気環境 9 10 11 12 13 14 NO 2 0.2ppm 0.1ppm 0.04ppm 06ppm 0.2ppm
More informationEPSON LP-S7500シリーズ 取扱説明書1 セットアップと使い方編
A B K L N N N N A B A N B N N A B D A B A B N N N N N N N N N N N K A B E C D F G N N N A B N N A A K B C D L E L L K F A B G N C N N C D B K E A B F AC N K G A B C H K D F E B G H K I G H L J
More informationⅠ.市場リスクの計測手法
1 2 3 4 { } n n 5 R R R R 1 6 7 8 9 , 10 11 12 13 14 15 T 16 T 17 18 19 20 21 22 23 99VaR 99 24 25 26 0.5 0.5 27 99 28 99 99 29 99 30 31 t-1 t-1 t-1 t-1 t-10 t-10 t-10 t-10 32 33 2 T 2 34 99 99 99 35 36
More information無印良品 キッチン・テーブル クリーニング・バス用品 2010春夏
200 6 6 7 8 2 4 6 6 7 7 7 2 8 8 9 9 9 20 20 2 22 22 22 24 24 24 25 26 26 28 28 29 29 30 30 3 www.muji.net 32 32 33 34 34 859275 35 39 4 42 35 36 35 37 36 38 39 40 40 40 4 4 42 44 43 45 46 47 47 48 49 50
More information無印良品 キッチン・テーブル・クリーニング・バス用品 2009 春夏
2009 2009 6 6 8 2 4 6 8 8 9 9 9 2 20 20 2 2 2 22 22 22 23 24 25 25 23 26 26 27 27 28 30 30 3 3 32 32 32 www.muji.net 34 34 35 35 35 36 36 37 37 37 38 39 854845 42 43 44 48 38 4 42 42 42 43 43 45 47 46
More information第4次酸性雨全国調査報告書(平成16年度) -(Ⅱ)付表編-
1.12.24 P. 5.4.3.1 NO NOP. 5.4.3.2P. 5.4.3.3 P. 5.4.3.4 P. 2.18 2.19 P. 2.20 P. 2.21 P. P. 5.5.2.11 SOA P. 5.5.2.12 NO B A B 1.1 16 mm FRS Vol. 31 42006 1.2 ph 16 FRS ms/m FRS 1.3 16 Vol. 31 42006 μmol/l
More informationhyou1.eps
CSR 2007 2007 CSR 1 Contents 3 How many? How much? 18 19 20 21 24 23 25 27 28 29 30 31 32 33 34 36 35 39 41 43 46 48 9 13 17 5 7 2 3 4 5 6 63 7 75 29,000 56 35 2002 3,949 2002 394 2002 8,343 2003 4,142
More information1 2 3 1 34060120 1,00040 2,000 1 5 10 50 2014B 305,000140 285 5 6 9 1,838 50 922 78 5025 50 10 1 2
0120-563-506 / 9001800 9001700 123113 0120-860-777 163-8626 6-13-1 Tel.03-6742-3111 http://www.himawari-life.co.jp 1 2 3 1 34060120 1,00040 2,000 1 5 10 50 2014B 305,000140 285 5 6 9 1,838 50 922 78 5025
More informationuntitled
.............................. ().......................................... 1 2 3 4 3.5 3 2.5 2 1.5 ( ( ( ( ( ( 1 2 3 4 3.5 3 2.5 2 1.5 1 2 3 4 3.5 3 2.5 2 1.5 1 2 3 4 3 2 2.5 1.5 3.5 1
More information第3章 焼却灰溶融システムの現状、焼却灰溶融スラグのリサイクルの動向・問題点
18 5 23 450 100~150 1300 1998 10 25 1 1 27 1819 60 3 300t 28.8t 2 62 118t16 12.3 16h 24 3 4 120t 9.6t24h 3 4 100t24h 15t24h 3 4 600t24h 500t24h 5 2 300t24h 75t24h 6 8 80 24h 9.6 24h 4 300t24h 52 24 11
More informationL- 19 L L- L-
0131001 15 1 31 49 35 145 14 5 19 4 23 15 3 10 7 15 634 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 L- 19 L- 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49
More informationA5_Catalog-US-JN_ indd
66 22 g 13 g 8 g 5 g 7500 IU 150% 300 mg 600 IU 100 IU 80 mcg 3 mg 3.5 mg 40 mg 4 mg 500 mcg 12 mcg 300 mcg 20 mg 1000 mg 150 mcg 400 mg 15 mg 105 mcg 2 mg 2 mg 180 mcg 125 mcg 15 mg 3.6 g ** 3.8 g **
More information62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC -
1 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] g/dl A 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - 62 [ ] [ ] [ ] [ ] [ ] [ ] / / [ ] 1T OTC - [ ] Point ~ 62 [ ] [ ] [ ] [ ] [ ] [ ] / /
More information1 2 3 1 2 3
2007 1 2 3 1 2 3 1 CONTENTS HP 2 3 3,303 323 150 479 2,350 521 335 1,492 4 5 1 6 7 2 8 1990 47 2006 9 10 3 11 12 ap1621 ap2627 ap2225 ap3035 ap3655 ap2829 13 14 15 3 1 3 2 1 5 4 1 4 2 2 3 4 HP 16 17 18
More informationレイアウト 1
1 3 6 7 8 3 6 7 8 g mg 6 1 16 16 18 16 13 138 13 16 1 11 8 78 8 17 9 9 g mg 18 13 1 1 1 99 6 3 36 3 3 8 1 18 18 18 16 16 1 1 g mg 1 1 13 13 1 11 11 g mg 8 6 g 1 g mg 93 38 9 93 8 8 176 1 1 1 1 11 18
More informationM.D.I VDT 29. (1)
5. 5. 5.1 (1 (2 (3 (4 3040 5.2 32 1 1 43 2 44 3 45 13 14 1) 4 45 2 5 46 6 47 7 66 2 8 26 2 1 32 2) 1 2 53 3 39 4 40 5 56 6 29 7 38 8 22 9 22 3 48 2 29 5. 17 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14.
More information(1) ) ) (2) (3) (4) (5) (1) (2) b (3)..
... -1... -1... -2... -6.... -1 (1)... -1 1)... -1 2)... -14 (2)... -19 (3)... -52 (4)... -18 (5)... -136.... -196 (1)... -196 (2) b... -224 (3)... -233.... -251.... -286.... -289 (1)... -289 (2)... -32
More information28 3 21 7 10 22 2 2
28 10 2 () 1 28 3 21 7 10 22 2 2 28 1. 2. () 28 6 29 11 3. 4. 5. ) 6. 7. 3 28 5 IC 28 5 28 6 1.5 2 28 7 1 28 9 28 9. OK 7 28 14 28 15 28 22 22 7 10 200 2 22 10 9 100 23 2 12 100 FAX 1 2 TEL FAX 16 28 20
More information105-117.PDF
47 2013. 1 6 1 1 2 1 1 2 19832002 2008 4 3 1 1 2008 1 3 6 1 1 22 3 A 24 3 3 2 22 910 3 6090 IC 4 5 A 3 143 133 99 27 27 A 6 1 3 6 1 1 C A C A 6 1 2 C B A B C 3 C 2 3 2 2 1 A OK B 2 C 3 3 3 3 1 B A 2 C
More information125 2 P 1st washout 2 PB P mg/dL nd washout 2 P 5.5mg/dL< mg/dL <2.5mg/dL P P 2 D D 3 Ca 10
. (1) 125 1 125 Renagel PB-94 P intact-pth P 1 b c a b 1 18 2 3 3 3 1 P 4 D 1 5 6 7 2 1HIV 2 3 4 5Hb 8.0g/dL ALT 48IU/L 6 7 PB-94 440mg 403mg 1-196 125 2 P 1st washout 2 PB-94 1 2 4 4 P 2.5 5.5mg/dL 1
More information06講義ノート.dvi
2006 2006 6 26 [ ] 1 1.1 1. 2. 3. 2 4. 1 GDP GDP BOD. COD. DO. eg.1 GNP CO 2 eg.2 eg. 1 No... eg. 2 2 eg. 3... 1.2 S 8000 1 1000 2 3 1: ( 1999 6 11 2 ) 10 200 10 20 123 20 30 33 30 40 14 40 50 13 50 60
More information1 (1) vs. (2) (2) (a)(c) (a) (b) (c) 31 2 (a) (b) (c) LENCHAR
() 601 1 () 265 OK 36.11.16 20 604 266 601 30.4.5 (1) 91621 3037 (2) 20-12.2 20-13 (3) ex. 2540-64 - LENCHAR 1 (1) vs. (2) (2) 605 50.2.13 41.4.27 10 10 40.3.17 (a)(c) 2 1 10 (a) (b) (c) 31 2 (a) (b) (c)
More information競技スポーツの科学研究 ~ アトランタ五輪を終えて ~ 新潟大学・山崎 健
1997 3 1998 12 sin cos 1997 3 1998 12 1997 3 1998 12 1997 3 1998 12 4 1997 3 1998 12 1964!? 100m 94 100m 100mH 10 100m 1964 1997 3 1998 12 1996 100m 7 0.174 0.14 9 84 1988 200m 25m 1986 1997 3 1998 12
More information% %
4 8 4 5 414.5 172.1 41.5% 39.8 10% 17 186.4 70.8 4 9 10 11 3 1-1 - 2-2 - - 3 - 10% - 4 - 4060% 5560% 60% 40% 3040 1520 1015 411 7 4 11 610 7080 5060 100 3040 13-5 - 1015 4045 3.04.0 5.06.0 1.52.0 1.01.5
More information152273335 1 123 11531 2 5 24 31 2 154301482 1551 JAS 100 2000 105 1101 1 2JAS 1-2 1
152273335 1 123 11531 2 5 24 31 2 154301482 1551 JAS 100 2000 105 1101 1 2JAS 1-2 1 JAS 1-2 1-2 112 13 1-11-13 100870mg 100830mg11000 1100020.002 2 50 100 2 100 500 2 100 109252165 4514782 7 2.0kg 2-19220.05kg0.2kg
More informationL- 11 12 13 15 15 17 17 18 21 23 25 25 27 29 29 30 31 32 32 33 36 36 36 37 37 37 38 39 39 40 42 42 45 46 48 10 48 11 49 11 50 50 50 51 51 51 51 52 52 53 53-54 12 55 55 57 28 3 6 4 8 7 6 100% 3 30 p.5760
More informationB000 B913 B913 S000 S500 L500 L913 B400 B913 B933 S320 L000 L913 492 498 P 38 5 P591 P595 P596 900 911 913 913 913 913 914 916 930 493 498 P 528 P594 P596 P597 910 913 913 913 913 913 914 918 700 723 746
More informationmaster
000000000 (1) 1064 B 5m78 091080067 6067 (0.80 52m59 100000000 (1) 0 B 9:52.00 101000744 744 (7. 8m79 101001650 650 12.50 101004483 (3) 3483 (0.80 52m36 101004486 (3) 3486 11.00 101004488 (3) 3488 50.00
More informationTaro10-mizushima01.PDF
- 1 - ATAGO N- % % g % g % g % g % g % g Brix% g g ml ml mgm / l ml mg mol/l mol/l mol/l ph NaSO mol/ l ml / g mg mg ml mol/l ml ml L- L- FIBE-MINI FIBE-MINI % % FIBE-MINI % g % g % g % C mg mg mg
More information糖尿病薬の保険調剤留意事項など
E-mail; west@gifu-shiya k u.ne t supported by 2 Road traffic accident risk in patients with diabetes mellitus receiving blood glucose-lowering drugs. Prospective follow-up study S. Skurtveit*, H. Strøm*,
More information48 * *2
374-1- 17 2 1 1 B A C A C 48 *2 49-2- 2 176 176 *2 -3- B A A B B C A B A C 1 B C B C 2 B C 94 2 B C 3 1 6 2 8 1 177 C B C C C A D A A B A 7 B C C A 3 C A 187 187 C B 10 AC 187-4- 10 C C B B B B A B 2 BC
More informationuntitled
DB -1- DB NOx NOx NO NO PM PM NOx NOx NO NO PM PM 49 49 54 54 52 52 61 61 62 62 57 57 63 63-2- NO -3- SPM -4- -5- - 6 - NOxPM -11- 76,892,517-12- NOPM -13-29.2% 63.9% 53.8% 85.1% -14-10 12-16- 13-17-
More information- 1 - 15 2030 4 21 21-2 - 2 1 21 21 4 22 31 10 5 26 ( JA ) - 3 - 4 21 7 9 9 34 1,386 1,003 94 58 1,155 60 25 33 1 3 2-4 - 12 17 60 7 7 12 H1217 4 7 30 34 19-5 - - 6 - (BMI*18.5) 20 15.2%30 8.% 20 86.4%30
More informationタミフルインタビューフォーム
2008 1 20 87625 IF 1998 9 75 3% 2 1 75mg 1 g 30mg Oseltamivir Phosphate 2000 12 12 2001 2 2 2001 2 2 2002 1 17 2002 4 26 2002 7 31 IF 2008 1 O H 2 N O H O CH 3 H 3 C N H H 3 PO 4 H H O H 3 C CH 3
More information2
1 2 3 4 5 6 7 8 9 10 11 12 ( ) RAND [OK] 0 1 13 14 15 16 17 18 19 20 21 1 22 23 24 25 26 27 28 ( ) DDE ( ) ( ) ( ) ( ): ( ): ( ): 29 30 1 1 1 1 31 32 33 34 35 36 37 38 39 40 41 : : : : : ( ) : : 1 42 43
More informationWord 2000 Standard
.1.1 [ ]-[ ] [ ] [ ] [ ] [ ] [ ] [ ] [ ] [OK] [ ] 1 .1.2 [ ]-[ ] [ ] [ ] [ [ ] [ ][ ] [ ] [ ] [ / ] [OK] [ ] [ ] [ ] [ ] 2 [OK] [ ] [ ] .2.1 [ ]-[ ] [F5] [ ] [ ] [] [ ] [ ] [ ] [ ] 4 ..1 [ ]-[ ] 5 ..2
More information橡資料1-1産業(前)b.PDF
1998 CO2 ( 474.5[ CO2] CO2 40% 34 12 1998 CO2 90 CO2 3.2 ( ( 1998 CO2 ( ( CO2 ( ( CO2 CO2 IIP( CO2 ( ( CO2 ( 98 CO2 98 180 90 1.8 (38 ( ( 9098 (90 20.7 (24.8 80 10 90 CO2 (1 CO2 IIP( (2 (3 90 98 90 90
More informationuntitled
Life Cycle Assessment (1998719993) (1998419991) (199913) 14 29 29 30 30 34 37 44 60 61 62 62 67 70 82 84 85 86 () ()() 1 PET 2.1.1 2.1-1 PTA 1997 72.6%2.6 97 4 2.1.2 2.1-2 1997 79.6% 2.3 2 2.1.3 PET 2.1-3
More informationuntitled
20 20 6 30 18 30 20 30 1 1 1 2 3 10 2 2 2 22 6 29 2 7 1 2 11 3 21 2 4 6 3 5 9 6 22 2 2 6 7 2 1 16 10 1 16 10 10 2 4 3 3 A4 3 1 2 3 1 55 8 4 63 11 4 8 8 4 8 12 2 17 11 4 4 4 8 12 3 5 4 8 4 12 5 5 6 19 2
More informationuntitled
Metabolic syndrome,,,, 81 81 , 17 17 2 Lung Ca non small cell carcinoma / / food( food( ) drug( drug( ) 100mg 750mg WBC 5510/ l RBC 483 / l Hb 10.3g/dl, Ht 42.0% Plt 19.0 / l TP 8.1g/dl Alb 4.6g/dl Glb
More informationIF MR 63 IF 10 IF IF IF IF A4 IF IF IF 11 IF IF IF IF MR IF IF MR Drug Safety Update() IF
200823 877122 IF19989 HYDROPHILIC OINTMENT 1g 250mg 200mg 120mg 60 40mg 10mg 1mg 1mg HydrophilicOintment 200821 19518 19977 IF20082 IF MR 63 IF 10 IF IF IF IF A4 IF IF IF 11 IF IF IF IF MR IF IF MR Drug
More informationunicharm_P02-25.indd
Contents SMILE S M Le SMILE Speedy correspondence Make products by customer s voice Interaction with I customers Lead customers to satisfaction 1 2 before after ton 213,995kWh
More information